Literature DB >> 2983207

Genetic screening for hemophilia A (classic hemophilia) with a polymorphic DNA probe.

I Oberle, G Camerino, R Heilig, L Grunebaum, J P Cazenave, C Crapanzano, P M Mannucci, J L Mandel.   

Abstract

We have developed a new method of screening for hemophilia A in families at risk for the disease. A DNA probe (St14) that detects a very polymorphic region on the human X chromosome has been shown to be closely linked to hemophilia A. We observed no recombination between the St14 locus and hemophilia A in 12 families studied. The odds in favor of linkage are 4.4 X 10(9) to 1 (lod score, 9.65). The 95 per cent confidence interval for the probability of a recombination between St14 and hemophilia A is 0 to 6.5 per cent. This DNA probe, which is informative in more than 90 per cent of families at risk of hemophilia A, can be used in conjunction with classic biologic assays to identify carriers with an accuracy of 96 per cent or more. If a small risk of misclassification due to crossover between the test and the disease loci is accepted, this DNA marker should allow first-trimester prenatal diagnosis of hemophilia A. Segregation analysis with St14 may thus represent a major improvement in genetic counseling for hemophilia A.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983207     DOI: 10.1056/NEJM198503143121103

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  37 in total

1.  Detection of four new TaqI alleles with probe St14-1.

Authors:  S Casares; M Olivera; M Vinuesa; J M Rodriguez
Journal:  Nucleic Acids Res       Date:  1991-12-11       Impact factor: 16.971

2.  Sex ratio of the mutation frequencies in haemophilia A: coagulation assays and RFLP analysis.

Authors:  A H Bröcker-Vriends; F R Rosendaal; J C van Houwelingen; E Bakker; G J van Ommen; J J van de Kamp; E Briët
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

3.  Investigation of factor VIII:C gene restriction fragment length polymorphisms and search for deletions in hemophiliac subjects in Algeria.

Authors:  K Nafa; F Meriane; A Reghis; M Benabadji; F Demenais; M Guilloud-Bataille; Y Sultan; J C Kaplan; M Delpech
Journal:  Hum Genet       Date:  1990-04       Impact factor: 4.132

4.  A gene for dominant nonspecific X-linked mental retardation is located in Xq28.

Authors:  V des Portes; P Billuart; A Carrié; L Bachner; T Bienvenu; M C Vinet; C Beldjord; G Ponsot; A Kahn; J Boué; J Chelly
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

5.  A new TaqI allele at DXS52 frequent in Algeria.

Authors:  K Nafa; A Reghis; M Benabadji; M Delpech; J C Kaplan
Journal:  Nucleic Acids Res       Date:  1989-02-11       Impact factor: 16.971

Review 6.  Molecular genetics of the human X chromosome.

Authors:  K E Davies
Journal:  J Med Genet       Date:  1985-08       Impact factor: 6.318

7.  Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: family studies indicate a mutation type-dependent sex ratio of mutation frequencies.

Authors:  J Becker; R Schwaab; A Möller-Taube; U Schwaab; W Schmidt; H H Brackmann; T Grimm; K Olek; J Oldenburg
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

8.  Interaction of incontinentia pigmenti and factor VIII mutations in a female with biased X inactivation, resulting in haemophilia.

Authors:  R Coleman; S A Genet; J I Harper; A O Wilkie
Journal:  J Med Genet       Date:  1993-06       Impact factor: 6.318

Review 9.  Haemophilia: strategies for carrier detection and prenatal diagnosis.

Authors:  I R Peake; D P Lillicrap; V Boulyjenkov; E Briet; V Chan; E K Ginter; E M Kraus; R Ljung; P M Mannucci; K Nicolaides
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

10.  X-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studies.

Authors:  D G Bichet; G N Hendy; M Lonergan; M F Arthus; S Ligier; Z Pausova; R Kluge; H Zingg; P Saenger; E Oppenheimer
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.